Ferrous Sulphate Supplement (V0355) in Women With Iron Deficiency Anaemia
Status:
Terminated
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the pharmacokinetics of serum iron after a single
oral administration of 160 mg (2 tablets of 80 mg) V0355 in women with iron deficiency
anaemia.